NCT03126721View on ClinicalTrials.gov

The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 18, 2017

Primary Completion Date

July 11, 2017

Study Completion Date

July 11, 2017

Conditions
Healthy
Interventions
DRUG

midazolam

a single oral dose of 2 mg midazolam

DRUG

PF-06751979

multiple oral doses of PF-06751979 100 mg a day

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03126721 - The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults | Biotech Hunter | Biotech Hunter